Health Care & Life Sciences » Pharmaceuticals | Alfresa Holdings Corp.

Alfresa Holdings Corp. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
156,021
167,311
160,174
168,430
195,884
206,310
Total Accounts Receivable
651,682
645,419
663,322
654,377
689,009
693,959
Inventories
130,919
131,327
133,270
132,102
133,729
133,710
Other Current Assets
8,604
7,883
8,369
7,961
8,390
2,803
Total Current Assets
947,226
951,940
965,135
962,872
1,027,015
1,036,784
Net Property, Plant & Equipment
110,467
118,766
130,489
133,196
136,886
141,528
Total Investments and Advances
87,695
120,863
120,667
125,397
148,494
123,877
Long-Term Note Receivable
-
2,031
2,269
2,094
2,158
1,807
Intangible Assets
9,384
10,650
14,952
13,800
12,138
17,427
Other Assets
14,295
16,265
18,996
17,718
15,823
16,918
Total Assets
1,169,546
1,220,781
1,253,494
1,255,922
1,343,284
1,341,939
ST Debt & Current Portion LT Debt
2,873
2,038
2,454
2,025
2,269
Accounts Payable
799,280
784,954
795,006
784,538
814,589
Income Tax Payable
2,023
8,777
12,628
4,654
10,460
Other Current Liabilities
19,895
23,802
25,424
23,359
26,917
Total Current Liabilities
824,071
819,571
835,512
814,576
854,235
Long-Term Debt
4,339
4,301
4,656
4,530
4,384
Provision for Risks & Charges
18,845
15,550
18,609
15,574
14,886
Deferred Taxes
15,478
25,618
23,553
25,692
31,956
Other Liabilities
898
1,352
1,451
1,153
1,119
Total Liabilities
864,110
866,658
884,767
862,367
907,346
Common Equity (Total)
305,234
352,520
366,542
392,335
434,769
Total Shareholders' Equity
305,234
352,520
366,542
392,335
434,769
Total Equity
305,436
354,123
368,727
393,550
435,934
Liabilities & Shareholders' Equity
1,169,546
1,220,781
1,253,494
1,255,917
1,343,280
Accumulated Minority Interest
202
1,603
2,185
1,215
1,165

About Alfresa Holdings

View Profile
Address
Ote Center Building, 23/F
Tokyo Tokyo 100
Japan
Employees -
Website http://www.alfresa.com
Updated 07/08/2019
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions.